Abstract: A solid pharmaceutical dosage form providing improved oral bioavailability is disclosed for inhibitors of HIV protease. In particular, the dosage form comprises a solid dispersion of at least one HIV protease inhibitor and at least one pharmaceutically acceptable water-soluble polymer and at least one pharmaceutically acceptable surfactant, said pharmaceutically acceptable water-soluble polymer having a Tg of at least about 50 °C. Preferably, the pharmaceutically acceptable surfactant has an HLB value of from about 4 to about 10.
attached
| # | Name | Date |
|---|---|---|
| 1 | 726-MUMNP-2009- FORM 18 (29-05-2009).pdf | 2009-05-29 |
| 1 | 726-MUMNP-2009-ABSTRACT(29-5-2009).pdf | 2018-08-10 |
| 2 | 726-MUMNP-2009- CORRESPONDENCE (03-12-2009).pdf | 2009-12-03 |
| 2 | 726-MUMNP-2009-ASSIGNMENT(29-5-2009).pdf | 2018-08-10 |
| 3 | 726-MUMNP-2009-CORRESPONDENCE(28-11-2011).pdf | 2011-11-28 |
| 3 | 726-MUMNP-2009-CLAIMS(29-5-2009).pdf | 2018-08-10 |
| 4 | 726-MUMNP-2009-CORRESPONDENCE(15-10-2012).pdf | 2012-10-15 |
| 4 | 726-MUMNP-2009-CLAIMS(COMPLETE)-(15-4-2009).pdf | 2018-08-10 |
| 5 | 726-MUMNP-2009-CORRESPONDENCE(IPO)-(16-10-2012).pdf | 2012-10-16 |
| 5 | 726-MUMNP-2009-CORRESPONDENCE(14-1-2010).pdf | 2018-08-10 |
| 6 | 726-MUMNP-2009-CORRESPONDENCE(29-10-2012).pdf | 2012-10-29 |
| 6 | 726-MUMNP-2009-CORRESPONDENCE(16-9-2011).pdf | 2018-08-10 |
| 7 | Priority Document.pdf | 2018-08-10 |
| 7 | 726-MUMNP-2009-CORRESPONDENCE(2-2-2011).pdf | 2018-08-10 |
| 8 | Form-5.pdf | 2018-08-10 |
| 8 | 726-MUMNP-2009-CORRESPONDENCE(29-5-2009).pdf | 2018-08-10 |
| 9 | 726-MUMNP-2009-CORRESPONDENCE(30-6-2009).pdf | 2018-08-10 |
| 9 | Form-3.pdf | 2018-08-10 |
| 10 | 726-MUMNP-2009-CORRESPONDENCE(5-3-2012).pdf | 2018-08-10 |
| 10 | Form-1.pdf | 2018-08-10 |
| 11 | 726-MUMNP-2009-CORRESPONDENCE(6-10-2009).pdf | 2018-08-10 |
| 11 | 726-MUMNP-2009_EXAMREPORT.pdf | 2018-08-10 |
| 12 | 726-MUMNP-2009-DESCRIPTION(COMPLETE)-(15-4-2009).pdf | 2018-08-10 |
| 12 | 726-MUMNP-2009-WO INTERNATIONAL PUBLICATION REPORT A3(29-5-2009).pdf | 2018-08-10 |
| 13 | 726-MUMNP-2009-DESCRIPTION(COMPLETE)-(29-5-2009).pdf | 2018-08-10 |
| 13 | 726-MUMNP-2009-WO INTERNATIONAL PUBLICATION REPORT A2(29-5-2009).pdf | 2018-08-10 |
| 14 | 726-MUMNP-2009-FORM 1(29-5-2009).pdf | 2018-08-10 |
| 14 | 726-MUMNP-2009-RECEIPT(IPO)-(29-5-2009).pdf | 2018-08-10 |
| 15 | 726-MUMNP-2009-FORM 18(6-10-2009).pdf | 2018-08-10 |
| 15 | 726-mumnp-2009-pregrant opposition(5-8-2010).pdf | 2018-08-10 |
| 16 | 726-mumnp-2009-form 2(29-5-2009).pdf | 2018-08-10 |
| 16 | 726-MUMNP-2009-PRE-GRANT OPPOSITION LETTER(1-3-2011).pdf | 2018-08-10 |
| 17 | 726-MUMNP-2009-PCT-RO-111(29-5-2009).pdf | 2018-08-10 |
| 17 | 726-MUMNP-2009-FORM 2(COMPLETE)-(15-4-2009).pdf | 2018-08-10 |
| 18 | 726-MUMNP-2009-FORM 2(TITLE PAGE)-(29-5-2009).pdf | 2018-08-10 |
| 18 | 726-MUMNP-2009-PCT-ISA-210(29-5-2009).pdf | 2018-08-10 |
| 19 | 726-MUMNP-2009-FORM 2(TITLE PAGE)-(COMPLETE)-(15-4-2009).pdf | 2018-08-10 |
| 19 | 726-MUMNP-2009-PCT-IB-304(29-5-2009).pdf | 2018-08-10 |
| 20 | 726-MUMNP-2009-FORM 3(29-5-2009).pdf | 2018-08-10 |
| 20 | 726-MUMNP-2009-PCT REQUEST(29-5-2009).pdf | 2018-08-10 |
| 21 | 726-MUMNP-2009-FORM 5(29-5-2009).pdf | 2018-08-10 |
| 21 | 726-MUMNP-2009-OTHER DOCUMENT(29-5-2009).pdf | 2018-08-10 |
| 22 | 726-MUMNP-2009-FORM 5(29-5-2009).pdf | 2018-08-10 |
| 22 | 726-MUMNP-2009-OTHER DOCUMENT(29-5-2009).pdf | 2018-08-10 |
| 23 | 726-MUMNP-2009-FORM 3(29-5-2009).pdf | 2018-08-10 |
| 23 | 726-MUMNP-2009-PCT REQUEST(29-5-2009).pdf | 2018-08-10 |
| 24 | 726-MUMNP-2009-PCT-IB-304(29-5-2009).pdf | 2018-08-10 |
| 24 | 726-MUMNP-2009-FORM 2(TITLE PAGE)-(COMPLETE)-(15-4-2009).pdf | 2018-08-10 |
| 25 | 726-MUMNP-2009-FORM 2(TITLE PAGE)-(29-5-2009).pdf | 2018-08-10 |
| 25 | 726-MUMNP-2009-PCT-ISA-210(29-5-2009).pdf | 2018-08-10 |
| 26 | 726-MUMNP-2009-FORM 2(COMPLETE)-(15-4-2009).pdf | 2018-08-10 |
| 26 | 726-MUMNP-2009-PCT-RO-111(29-5-2009).pdf | 2018-08-10 |
| 27 | 726-mumnp-2009-form 2(29-5-2009).pdf | 2018-08-10 |
| 27 | 726-MUMNP-2009-PRE-GRANT OPPOSITION LETTER(1-3-2011).pdf | 2018-08-10 |
| 28 | 726-MUMNP-2009-FORM 18(6-10-2009).pdf | 2018-08-10 |
| 28 | 726-mumnp-2009-pregrant opposition(5-8-2010).pdf | 2018-08-10 |
| 29 | 726-MUMNP-2009-FORM 1(29-5-2009).pdf | 2018-08-10 |
| 29 | 726-MUMNP-2009-RECEIPT(IPO)-(29-5-2009).pdf | 2018-08-10 |
| 30 | 726-MUMNP-2009-DESCRIPTION(COMPLETE)-(29-5-2009).pdf | 2018-08-10 |
| 30 | 726-MUMNP-2009-WO INTERNATIONAL PUBLICATION REPORT A2(29-5-2009).pdf | 2018-08-10 |
| 31 | 726-MUMNP-2009-DESCRIPTION(COMPLETE)-(15-4-2009).pdf | 2018-08-10 |
| 31 | 726-MUMNP-2009-WO INTERNATIONAL PUBLICATION REPORT A3(29-5-2009).pdf | 2018-08-10 |
| 32 | 726-MUMNP-2009-CORRESPONDENCE(6-10-2009).pdf | 2018-08-10 |
| 32 | 726-MUMNP-2009_EXAMREPORT.pdf | 2018-08-10 |
| 33 | 726-MUMNP-2009-CORRESPONDENCE(5-3-2012).pdf | 2018-08-10 |
| 33 | Form-1.pdf | 2018-08-10 |
| 34 | 726-MUMNP-2009-CORRESPONDENCE(30-6-2009).pdf | 2018-08-10 |
| 34 | Form-3.pdf | 2018-08-10 |
| 35 | 726-MUMNP-2009-CORRESPONDENCE(29-5-2009).pdf | 2018-08-10 |
| 35 | Form-5.pdf | 2018-08-10 |
| 36 | Priority Document.pdf | 2018-08-10 |
| 36 | 726-MUMNP-2009-CORRESPONDENCE(2-2-2011).pdf | 2018-08-10 |
| 37 | 726-MUMNP-2009-CORRESPONDENCE(29-10-2012).pdf | 2012-10-29 |
| 37 | 726-MUMNP-2009-CORRESPONDENCE(16-9-2011).pdf | 2018-08-10 |
| 38 | 726-MUMNP-2009-CORRESPONDENCE(IPO)-(16-10-2012).pdf | 2012-10-16 |
| 38 | 726-MUMNP-2009-CORRESPONDENCE(14-1-2010).pdf | 2018-08-10 |
| 39 | 726-MUMNP-2009-CORRESPONDENCE(15-10-2012).pdf | 2012-10-15 |
| 39 | 726-MUMNP-2009-CLAIMS(COMPLETE)-(15-4-2009).pdf | 2018-08-10 |
| 40 | 726-MUMNP-2009-CORRESPONDENCE(28-11-2011).pdf | 2011-11-28 |
| 40 | 726-MUMNP-2009-CLAIMS(29-5-2009).pdf | 2018-08-10 |
| 41 | 726-MUMNP-2009-ASSIGNMENT(29-5-2009).pdf | 2018-08-10 |
| 41 | 726-MUMNP-2009- CORRESPONDENCE (03-12-2009).pdf | 2009-12-03 |
| 42 | 726-MUMNP-2009- FORM 18 (29-05-2009).pdf | 2009-05-29 |
| 42 | 726-MUMNP-2009-ABSTRACT(29-5-2009).pdf | 2018-08-10 |